Getty ImagesRelated
ICICI Securities has buy call on with a target price of Rs 200. The current market price of Jyothy Labs Ltd. is Rs 155.35. Time period given by analyst is one year when Jyothy Labs Ltd. price can reach defined target. Jyothy Labs Ltd., incorporated in the year 1992, is a Mid Cap company (having a market cap of Rs 5710.09 Crore) operating in FMCG sector.
Jyothy Labs Ltd. key Products/Revenue Segments include Personal Care and Scrap for the year ending 31-Mar-2021.
Financials
For the quarter ended 30-09-2021, the company reported a Consolidated Total Income of Rs 590.11 Crore, up 11.35 % from last quarter Total Income of Rs 529.95 Crore and up 16.05 % from last year same quarter Total Income of Rs 508.51 Crore. Company reported net profit after tax of Rs 43.97 Crore in latest quarter.
Investment Rationale
The brokerage cuts earnings estimates by ~22%-4% for FY22 and FY23E. It models revenue / EBITDA / PAT CAGR of 12 / 12 / 15 (%) over FY21- 23E. It maintains BUY with unchanged DCF-based target price of Rs200. At the target price, the stock will trade at 25x P/E multiple Mar-23E. Key downside risks are high competitive pressure and RM inflation impacting margins.
Promoter/FII Holdings
Promoters held 62.89 per cent stake in the company as of 30-Sep-2021, while FIIs owned 12.23 per cent, DIIs 16.38 per cent.
Jyothy Labs Ltd. key Products/Revenue Segments include Personal Care and Scrap for the year ending 31-Mar-2021.
Financials
For the quarter ended 30-09-2021, the company reported a Consolidated Total Income of Rs 590.11 Crore, up 11.35 % from last quarter Total Income of Rs 529.95 Crore and up 16.05 % from last year same quarter Total Income of Rs 508.51 Crore. Company reported net profit after tax of Rs 43.97 Crore in latest quarter.
Investment Rationale
The brokerage cuts earnings estimates by ~22%-4% for FY22 and FY23E. It models revenue / EBITDA / PAT CAGR of 12 / 12 / 15 (%) over FY21- 23E. It maintains BUY with unchanged DCF-based target price of Rs200. At the target price, the stock will trade at 25x P/E multiple Mar-23E. Key downside risks are high competitive pressure and RM inflation impacting margins.
Promoter/FII Holdings
Promoters held 62.89 per cent stake in the company as of 30-Sep-2021, while FIIs owned 12.23 per cent, DIIs 16.38 per cent.
(Disclaimer: Recommendations given in this section or any reports attached herein are authored by an external party. Views expressed are that of the respective authors/entities. These do not represent the views of Economic Times (ET). ET does not guarantee, vouch for, endorse any of its contents and hereby disclaims all warranties, express or implied, relating to the same. Please consult your financial adviser and seek independent advice.
Pick the best companies to invest
BECOME AN ETPRIME MEMBERRead More News on
Download The Economic Times News App to get Daily Market Updates & Live Business News.
